Photoswitchable Azo- and Diazocine-Functionalized Derivatives of the VEGFR-2 Inhibitor Axitinib
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International journal of molecular sciences(21), H. 23
- Ereignis
-
Veröffentlichung
- (wo)
-
Kiel
- (wer)
-
Universitätsbibliothek Kiel
- (wann)
-
2020
- Urheber
-
Heintze, Linda
Schmidt, Dorian
Rodat, Theo
Witt, Lydia
Ewert, Julia
Kriegs, Malte
Herges, Rainer
Peifer, Christian
- DOI
-
10.3390/ijms21238961
- URN
-
urn:nbn:de:gbv:8:3-2022-00332-4
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Heintze, Linda
- Schmidt, Dorian
- Rodat, Theo
- Witt, Lydia
- Ewert, Julia
- Kriegs, Malte
- Herges, Rainer
- Peifer, Christian
- Universitätsbibliothek Kiel
Entstanden
- 2020
Ähnliche Objekte (12)
Functionalized amphiphilic fullerene derivatives
Photoswitchable and non-photoswitchable tubulin inhibitors for applications in cell biology
Photoswitchable Kinase Inhibitors to Reversibly Control Kinase Activity
Photoswitchable protein kinase Inhibitors for novel anti-cancer applications
Introducing a photo-switchable azo-functionality inside Cr-MIL-101-NH2 by covalent post-synthetic modification
Photopharmacology on Acetylcholinesterase: Novel Photoswitchable Inhibitors with Improved Pharmacological Profiles
Reversible optical control of F1Fo‐ATP synthase using photoswitchable inhibitors
![[Azo].](https://iiif.deutsche-digitale-bibliothek.de/image/2/3bc6abde-239b-4f70-bfe7-f4befdc9028a/full/!306,450/0/default.jpg)
[Azo].
AZO
Functionalized Prodrugs of a bacterial RNAP-Inhibitor & Bio-reversibly masked purinergic 2nd Messenger derivatives associated with Ca2+ Signaling
Syntheses of nipecotic acid derivatives with new N-arylalkenyl and N-arylalkynyl substituents and with new photoswitchable residues as mGAT1 inhibitors
Activation of Sirtuin 2 Inhibitors Employing Photoswitchable Geometry and Aqueous Solubility
Functionalized amphiphilic fullerene derivatives
Photoswitchable and non-photoswitchable tubulin inhibitors for applications in cell biology
Photoswitchable Kinase Inhibitors to Reversibly Control Kinase Activity
Photoswitchable protein kinase Inhibitors for novel anti-cancer applications
Introducing a photo-switchable azo-functionality inside Cr-MIL-101-NH2 by covalent post-synthetic modification
Photopharmacology on Acetylcholinesterase: Novel Photoswitchable Inhibitors with Improved Pharmacological Profiles
Reversible optical control of F1Fo‐ATP synthase using photoswitchable inhibitors
[Azo].
AZO
Functionalized Prodrugs of a bacterial RNAP-Inhibitor & Bio-reversibly masked purinergic 2nd Messenger derivatives associated with Ca2+ Signaling
Syntheses of nipecotic acid derivatives with new N-arylalkenyl and N-arylalkynyl substituents and with new photoswitchable residues as mGAT1 inhibitors
Activation of Sirtuin 2 Inhibitors Employing Photoswitchable Geometry and Aqueous Solubility
Functionalized amphiphilic fullerene derivatives
Photoswitchable and non-photoswitchable tubulin inhibitors for applications in cell biology
Photoswitchable Kinase Inhibitors to Reversibly Control Kinase Activity
Photoswitchable protein kinase Inhibitors for novel anti-cancer applications
Introducing a photo-switchable azo-functionality inside Cr-MIL-101-NH2 by covalent post-synthetic modification
Photopharmacology on Acetylcholinesterase: Novel Photoswitchable Inhibitors with Improved Pharmacological Profiles
Reversible optical control of F1Fo‐ATP synthase using photoswitchable inhibitors
[Azo].
AZO
Functionalized Prodrugs of a bacterial RNAP-Inhibitor & Bio-reversibly masked purinergic 2nd Messenger derivatives associated with Ca2+ Signaling
Syntheses of nipecotic acid derivatives with new N-arylalkenyl and N-arylalkynyl substituents and with new photoswitchable residues as mGAT1 inhibitors